Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02441842Phase 4Completed
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Atenolol, Lisinopril and Placebo (3 arms). Primary endpoints: Mean Arterial Pressure changes and Heart Rate changes. Started Mar 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02441842.